Kelly A. Metcalfe, Ph.D.
Affiliations: | 2002 | University of Toronto, Toronto, ON, Canada |
Area:
Medicine and Surgery, OncologyGoogle:
"Kelly Metcalfe"Parents
Sign in to add mentorSteven A. Narod | grad student | 2002 | University of Toronto | |
(Prophylactic bilateral mastectomy in Ontario.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Kotsopoulos J, Gronwald J, Huzarski T, et al. (2024) Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations. Jama Oncology |
Lubinski J, Kotsopoulos J, Moller P, et al. (2024) MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations. Jama Oncology |
Metcalfe K, Huzarski T, Gronwald J, et al. (2023) Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis. British Journal of Cancer |
Metcalfe KA, Pal T, Narod SA, et al. (2023) Theory-based behavior change intervention to increase uptake of risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 pathogenic variant: The PREVENT randomized controlled trial. Cancer Medicine |
Kotsopoulos J, Gronwald J, Huzarski T, et al. (2023) Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation. Breast Cancer Research and Treatment. 201: 257-264 |
Evans DG, Phillips KA, Milne RL, et al. (2023) Correction to: Survival from breast cancer in women with a BRCA2 mutation by treatment. British Journal of Cancer |
Metcalfe KA, Gronwald J, Tung NM, et al. (2022) The risks of cancer in older women with BRCA pathogenic variants: How far have we come? Cancer |
Metcalfe KA, Narod SA, Eisen A, et al. (2022) Genetic testing women with newly diagnosed breast cancer: What criteria are the most predictive of a positive test? Cancer Medicine |
Tindale LC, Zhantuyakova A, Lam S, et al. (2022) Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention. Current Oncology (Toronto, Ont.). 29: 4632-4646 |
Carlsson L, Thain E, Gillies B, et al. (2022) Psychological and health behaviour outcomes following multi-gene panel testing for hereditary breast and ovarian cancer risk: a mini-review of the literature. Hereditary Cancer in Clinical Practice. 20: 25 |